Inflammatory breast cancer is a relatively rare disease that usually induces the appearance of adverse symptoms such as diffuse hardening and enlargement, as well as skin redness and heat pain. For the treatment of inflammatory breast cancer, surgery is not recommended. Neoadjuvant therapy is recommended. Breast cancer must be reduced to meet the conditions of surgical treatment.

　　 In real life, due to some Such as bad habits, or the influence of bad lifestyle habits, which has caused many patients to develop cancers such as inflammatory breast cancer, which has caused great harm to their physical health and also brought them a lot of spirit. Bothered. So, what is inflammatory breast cancer?
　　Inflammatory breast cancer is an extremely rare clinical type, which is often diffusely hardened and enlarged, with red, swollen, hot, painful, and edema, and the onset is explosive, very similar to acute inflammation, so Called cancerous mastitis.
　　Diagnostic points of this disease are as follows:
　　 First, although the local manifestations are red, swollen, hot, and painful, there are no systemic inflammation reactions such as chills and fever.
　　 Second, body temperature and white blood cell count are mostly in the normal range.
　　 Third, the early skin is typically violet, with patchy edema, the boundary is very clear, the edge is slightly raised, and the redness does not disappear after a week of anti-inflammatory treatment.
　　 Fourth, in the red and swollen breast tissue, sometimes it can touch the tough lump.
　　Fifth, the ipsilateral axillary can reach harder lymph nodes.
　　 Sixth, fine needle aspiration cytology and pathological section can provide diagnostic basis. In the past, surgery for inflammatory breast cancer has been used, and the prognosis of treatment is very poor, with an average survival time of only 4-9 months. Therefore, it is not recommended to directly use surgical treatment for inflammatory breast cancer. The above content is for reference only, please refer to the doctor''s interview for specific medication and treatment.
　　Inflammatory breast cancer is a special pathological type in breast cancer. The course of disease progresses rapidly, which can affect the entire breast, and the prognosis is relatively poor. Inflammatory breast cancer is usually treated with neoadjuvant therapy. After the neoadjuvant therapy in stage Ⅰ-Ⅱ, the treatment results are evaluated. If the mass is significantly reduced, the neoadjuvant therapy is proved to be effective and the drug has an inhibitory effect on the tumor.
　　Generally speaking, as long as patients with inflammatory breast cancer undergo neoadjuvant therapy to promote the degradation of breast cancer, they can meet the surgical treatment conditions, and then completely remove the cancer mass by surgical treatment. Improve patient survival.